Skip to main content
Erschienen in: Pediatric Nephrology 5/2009

01.05.2009 | Brief Report

Increased chymase-positive mast cells in children with crescentic glomerulonephritis

verfasst von: Hiroko Togawa, Koichi Nakanishi, Yuko Shima, Mina Obana, Mayumi Sako, Kandai Nozu, Ryojiro Tanaka, Kazumoto Iijima, Norishige Yoshikawa

Erschienen in: Pediatric Nephrology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Mast cell-derived chymase is an angiotensin II-forming enzyme that appears to be involved in tubulointerstitial fibrosis in the kidneys. Previous studies have shown that the level of chymase increases in grafted kidneys after rejection and in adult patients with diabetic nephropathy. However, the significance of chymase in children with renal diseases has not been investigated. Using immunohistochemistry, we have investigated chymase expression in biopsy samples of renal tissue from 104 children with kidney diseases, including rapidly progressive crescentic glomerulonephritis (n = 3), diabetic nephropathy (n = 2), allografted kidney (n = 3), membranoproliferative glomerulonephritis (n = 6), immunoglobulin A nephropathy (n = 33) and Henoch–Schönlein purpura nephritis (n = 23). Increased numbers of chymase-positive mast cells were observed in the renal cortex of all three patients with crescentic glomerulonephritis (mean 26.0/mm2; range 19.3–36.8/mm2). Chymase-positive cells were also observed in the renal biopsy of an allografted kidney and in those from children with diabetic nephropathy. The mean number of chymase-positive cells in renal tissue samples characterized by each renal disease was significantly correlated with the mean intensity of the interstitial fibrosis in that same tissue sample (Spearman’s rank correlation test p = 0.0013; rank correlation coefficient  0.84). These findings suggest that mast cell-derived chymase plays an important role in juvenile crescentic glomerulonephritis.
Literatur
1.
Zurück zum Zitat Yamada M, Ueda M, Naruko T, Tanabe S, Han YS, Ikura Y, Ogami M, Takai S, Miyazaki M (2001) Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 59:1374–1381CrossRef Yamada M, Ueda M, Naruko T, Tanabe S, Han YS, Ikura Y, Ogami M, Takai S, Miyazaki M (2001) Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 59:1374–1381CrossRef
2.
Zurück zum Zitat Ritz E (2003) Chymase: a potential culprit in diabetic nephropathy? J Am Soc Nephrol 14:1738–1747CrossRef Ritz E (2003) Chymase: a potential culprit in diabetic nephropathy? J Am Soc Nephrol 14:1738–1747CrossRef
3.
Zurück zum Zitat Huang XR, Chen WY, Truong LD, Lan HY (2003) Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 14:1738–1747CrossRef Huang XR, Chen WY, Truong LD, Lan HY (2003) Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 14:1738–1747CrossRef
4.
Zurück zum Zitat Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S (2005) Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 25:1–12CrossRef Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S (2005) Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 25:1–12CrossRef
5.
Zurück zum Zitat Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen ST, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkiv K, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723CrossRef Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen ST, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkiv K, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723CrossRef
6.
Zurück zum Zitat Churg J, Bernstein J, Glassock RJ (1995) Renal disease: classification and atlas of glomerular diseases, 2nd edn. Igaku-shoin Medical Publishers Tokyo Churg J, Bernstein J, Glassock RJ (1995) Renal disease: classification and atlas of glomerular diseases, 2nd edn. Igaku-shoin Medical Publishers Tokyo
7.
Zurück zum Zitat Yoshikawa N, Nakanishi K, Iijima K (2001) Henoch-Schönlein purpura. In: Neilson EG, Couser WG (eds) Immunologic renal diseases, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1127–1140 Yoshikawa N, Nakanishi K, Iijima K (2001) Henoch-Schönlein purpura. In: Neilson EG, Couser WG (eds) Immunologic renal diseases, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1127–1140
8.
Zurück zum Zitat Tóth T, Tóth-Jakatics R, Jimi S, Ihara M, Urata H, Takebayashi S (1999) Mast cells in rapidly progressive glomerulonephritis. J Am Soc Nephrol 10:1498–1505PubMed Tóth T, Tóth-Jakatics R, Jimi S, Ihara M, Urata H, Takebayashi S (1999) Mast cells in rapidly progressive glomerulonephritis. J Am Soc Nephrol 10:1498–1505PubMed
9.
Zurück zum Zitat Ehara T, Shigematsu H (1998) Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 54:1675–1683CrossRef Ehara T, Shigematsu H (1998) Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 54:1675–1683CrossRef
10.
Zurück zum Zitat Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M (2006) Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant 21:3466–3474CrossRef Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M (2006) Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant 21:3466–3474CrossRef
11.
Zurück zum Zitat Blank U, Essig M, Scandiuzzi L, Benhamou M, Kanamaru Y (2007) Mast cells and inflammatory kidney disease. Immunol Rev 217:79–95CrossRef Blank U, Essig M, Scandiuzzi L, Benhamou M, Kanamaru Y (2007) Mast cells and inflammatory kidney disease. Immunol Rev 217:79–95CrossRef
12.
Zurück zum Zitat Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G (2005) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280:9291–9296CrossRef Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G (2005) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280:9291–9296CrossRef
13.
Zurück zum Zitat Hollenberg NK, Fisher ND, Price DA (1998) Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension 32:387–392CrossRef Hollenberg NK, Fisher ND, Price DA (1998) Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension 32:387–392CrossRef
Metadaten
Titel
Increased chymase-positive mast cells in children with crescentic glomerulonephritis
verfasst von
Hiroko Togawa
Koichi Nakanishi
Yuko Shima
Mina Obana
Mayumi Sako
Kandai Nozu
Ryojiro Tanaka
Kazumoto Iijima
Norishige Yoshikawa
Publikationsdatum
01.05.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 5/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1044-2

Weitere Artikel der Ausgabe 5/2009

Pediatric Nephrology 5/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.